LQDA Liquidia Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: LQDA

Price (delayed)

$12.79

Market cap

$972.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.21

Enterprise value

$938.25M

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries, ...

Highlights
LQDA's gross profit is up by 12% year-on-year but it is down by 7% since the previous quarter
LQDA's revenue is up by 10% YoY but it is down by 4.5% QoQ
The company's debt has surged by 102% YoY and by 2.1% QoQ
LQDA's net income has plunged by 91% YoY and by 36% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://liquidia.com
Peers: OMER OMGA

Key stats

What are the main financial stats of LQDA
Market
Shares outstanding
76.03M
Market cap
$972.4M
Enterprise value
$938.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
17.55
Price to sales (P/S)
47.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
53.65
Earnings
Revenue
$17.49M
EBIT
-$72.23M
EBITDA
-$69.65M
Free cash flow
-$42.85M
Per share
EPS
-$1.21
Free cash flow per share
-$0.66
Book value per share
$0.73
Revenue per share
$0.27
TBVPS
$1.71
Balance sheet
Total assets
$118.33M
Total liabilities
$71.04M
Debt
$49.54M
Equity
$47.29M
Working capital
$71.35M
Liquidity
Debt to equity
1.05
Current ratio
4.85
Quick ratio
4.73
Net debt/EBITDA
0.49
Margins
EBITDA margin
-398.3%
Gross margin
83.5%
Net margin
-448.9%
Operating margin
-419.6%
Efficiency
Return on assets
-65.4%
Return on equity
-132.2%
Return on invested capital
-129.2%
Return on capital employed
-72.4%
Return on sales
-413%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LQDA stock price

How has the Liquidia stock price performed over time
Intraday
-1.46%
1 week
2.08%
1 month
-16.68%
1 year
81.42%
YTD
6.32%
QTD
-13.29%

Financial performance

How have Liquidia's revenue and profit performed over time
Revenue
$17.49M
Gross profit
$14.6M
Operating income
-$73.38M
Net income
-$78.5M
Gross margin
83.5%
Net margin
-448.9%
LQDA's net income has plunged by 91% YoY and by 36% from the previous quarter
LQDA's operating income has dropped by 89% year-on-year and by 37% since the previous quarter
The company's net margin has shrunk by 74% YoY and by 43% QoQ
The company's operating margin has shrunk by 72% YoY and by 44% QoQ

Growth

What is Liquidia's growth rate over time

Valuation

What is Liquidia stock price valuation
P/E
N/A
P/B
17.55
P/S
47.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
53.65
Liquidia's EPS has shrunk by 81% YoY and by 39% QoQ
The stock's P/B is 193% above its 5-year quarterly average of 6.0 and 81% above its last 4 quarters average of 9.7
LQDA's equity is down by 48% year-on-year
The stock's price to sales (P/S) is 65% more than its 5-year quarterly average of 28.8 and 56% more than its last 4 quarters average of 30.5
LQDA's revenue is up by 10% YoY but it is down by 4.5% QoQ

Efficiency

How efficient is Liquidia business performance
The ROE has plunged by 177% YoY and by 61% from the previous quarter
The ROA has plunged by 97% YoY and by 39% from the previous quarter
Liquidia's return on sales has shrunk by 70% YoY and by 44% QoQ
The ROIC has contracted by 48% YoY and by 29% from the previous quarter

Dividends

What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LQDA.

Financial health

How did Liquidia financials performed over time
The total assets is 67% more than the total liabilities
The company's total liabilities has surged by 83% YoY and by 12% QoQ
The quick ratio has shrunk by 58% YoY and by 28% QoQ
The company's debt is 4.7% higher than its equity
The company's debt has surged by 102% YoY and by 2.1% QoQ
LQDA's equity is down by 48% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.